Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda clinical programs — 1179 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
1179
Drugs
359
Patents
1436
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Takeda projects

1,179 ClinicalTrials.gov programs sponsored by Takeda.

Takeda has 1,179 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,179 programs

Clinical programs

Page 16 of 25

  1. ponatinib - Phase 1

    Takeda

    Chronic Myeloid Leukemia (CML)

    phase 2 small molecule completed

    1 trial

  2. rhHNS-10 mg

    Takeda

    Sanfilippo Syndrome

    phase 2 mab terminated

    1 trial

  3. rhIGF-1/rhIGFBP-3

    Takeda

    Retinopathy of Prematurity (ROP)

    phase 2 small molecule completed

    1 trial

  4. rhIGF-I/rhIGFBP-3

    Takeda

    Retinopathy of Prematurity (ROP)

    phase 2 small molecule completed

    1 trial

  5. troxacitabine

    Takeda

    Leukemia

    phase 2 small molecule completed

    1 trial

  6. velaglucerase alfa

    Takeda

    Gaucher Disease, Type 3

    phase 2 mab completed

    1 trial

  7. vortioxetine (Lu AA21004)

    Takeda

    Depressive Disorder, Major

    phase 2 small molecule completed

    1 trial

  8. ΕΑΕ-2018/ΜΜ03

    Takeda

    Multiple Myeloma

    phase 2 small molecule active

    1 trial

  9. 19(T2)28z1xx CAR T cells

    Takeda

    Diffuse Large B Cell Lymphoma

    phase 1 small molecule active

    1 trial

  10. 19(T2)28z1xx TRAC T cell

    Takeda

    B-Cell Lymphoma

    phase 1 mab active

    1 trial

  11. 25mcg rhPTH(1-84)

    Takeda

    Hypoparathyroidism

    phase 1 small molecule completed

    1 trial

  12. 30 mg dexlansoprazole capsules manufactured at TOB

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  13. ACTOS (Pioglitazone)

    Takeda

    Multiple Sclerosis, Relapsing-Remitting

    phase 1 small molecule completed

    1 trial

  14. ADCLEC.syn1 CAR T cells

    Takeda

    Acute Myeloid Leukemia

    phase 1 mab active

    1 trial

  15. Adjuvant/Excipients

    Takeda

    Norovirus

    phase 1 small molecule completed

    1 trial

  16. Alisertib

    Takeda

    Advanced Solid Tumors

    phase 1 small molecule completed

    7 trials

  17. Alisertib

    Takeda

    B-cell Follicular Lymphoma

    phase 1 small molecule completed

    1 trial

  18. Alisertib

    Takeda

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  19. Alogliptin

    Takeda

    Pharmacokinetics and Pharmacodynamics

    phase 1 small molecule completed

    1 trial

  20. Alogliptin

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  21. Amoxicillin + MMX placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  22. Anagrelide 0.5 mg

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  23. Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody

    Takeda

    Metastatic Adenocarcinoma of the Colon or Rectum

    phase 1 mab completed

    1 trial

  24. Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody

    Takeda

    Systemic Lupus Erythematosus

    phase 1 small molecule terminated

    1 trial

  25. Azilsartan medoxomil (TAK-491)

    Takeda

    Hypertension

    phase 1 small molecule terminated

    1 trial

  26. BAX 826

    Takeda

    Hemophilia A

    phase 1 mab completed

    1 trial

  27. Binimetinib

    Takeda

    ALK Gene Rearrangement

    phase 1 small molecule terminated

    1 trial

  28. Brentuximab Vedotin

    Takeda

    Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic

    phase 1 small molecule terminated

    1 trial

  29. Brigatinib

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  30. Budesonide

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  31. Calcichew D3

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  32. Calcitriol

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  33. Calcium 500 mg and Vitamin D3 800 IU

    Takeda

    Calcium Deficiency

    phase 1 small molecule completed

    1 trial

  34. Ciprofloxacin XR + MMX Placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  35. Clarithromycin

    Takeda

    Helicobacter Pylori

    phase 1 small molecule completed

    2 trials

  36. Clopidogrel

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  37. DHAP

    Takeda

    Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  38. Danavorexton

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  39. Daratumumab

    Takeda

    Newly Diagnosed Primary Amyloidosis

    phase 1 mab active

    1 trial

  40. Deferitazole (disodium salt, granule)

    Takeda

    Healthy

    phase 1 small molecule terminated

    1 trial

  41. Dexlansoprazole

    Takeda

    Pediatric Gastroesophageal Reflux Disease

    phase 1 small molecule terminated

    1 trial

  42. Dexlansoprazole

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  43. Dexlansoprazole

    Takeda

    Homeostasis

    phase 1 small molecule completed

    1 trial

  44. Dexlansoprazole Delayed Release Orally Disintegrating Tablets

    Takeda

    Bioavailability

    phase 1 small molecule completed

    1 trial

  45. Dexlansoprazole MR

    Takeda

    Gastroesophageal Reflux

    phase 1 small molecule completed

    1 trial

  46. Digoxin

    Takeda

    Cytomegalovirus (CMV)

    phase 1 small molecule completed

    1 trial

  47. Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor

    Takeda

    Alpha 1-Antitrypsin Deficiency

    phase 1 mab completed

    1 trial

  48. Esomeprazole Capsule

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Takeda have?

1,179 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.